Maxwell v. Tran (In re Controlled Release Technologies, Inc.)

163 B.R. 519, 28 Fed. R. Serv. 3d 845, 1994 Bankr. LEXIS 93
CourtUnited States Bankruptcy Court, N.D. Illinois
DecidedJanuary 4, 1994
DocketBankruptcy No. 90 B 3688; Adv. No. 91 A 746
StatusPublished
Cited by1 cases

This text of 163 B.R. 519 (Maxwell v. Tran (In re Controlled Release Technologies, Inc.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maxwell v. Tran (In re Controlled Release Technologies, Inc.), 163 B.R. 519, 28 Fed. R. Serv. 3d 845, 1994 Bankr. LEXIS 93 (Ill. 1994).

Opinion

MEMORANDUM OPINION AND ORDER

ROBERT E. GINSBERG, Bankruptcy Judge.

This matter is before the court on the motion of the Defendants, Loi Tran and Biomedcare Corporation under Fed.R.Civ.P. 60(b), made applicable to adversary proceedings in bankruptcy cases by Fed.R.Bankr.P. 9024, to vacate a default judgment entered by this court in an adversary proceeding brought by the Trustee against the Defendants. For the reasons stated below, the court vacates the default judgment.1

FACTS

The Debtor, Controlled Release Technologies, Inc. (“CRT”), was in the business of developing and manufacturing biomedical products. Loi Tran (“Tran”) has been the Debtor’s president and chief executive officer since its inception in 1986. Among the Debt- or’s assets are four patents for a controlled release drug delivery system which the Debt- or manufactured and marketed under the trade name “Micros.” The Debtor obtained the patents largely as a result of Tran’s research efforts.

On February 27, 1990, an involuntary petition under Chapter 7 of the Bankruptcy Code was filed against the Debtor. After a number of hearings, the Debtor consented to the entry of an order for relief under Chapter 7 on April 5, 1990. The Debtor immediately exercised its right to convert the Chapter 7 case to one under Chapter 11. See 11 U.S.C. § 706(a). Subsequently, after, serious questions arose with respect to Tran’s man[521]*521agement of the Debtor, his efforts to frustrate the bankruptcy case by moving the business and certain of its assets from Illinois to California, and possible material misrepresentations by Tran in his efforts to raise capital for the Debtor from public investors, the court ordered the United States Trustee to appoint a Chapter 11 trustee. On July 9, 1990, the United States Trustee appointed Andrew J. Maxwell as Chapter 11 trustee. The Trustee took over the Debtor’s assets and business in both Illinois and California to the exclusion of Tran, and Tran was denied access to the Debtor’s premises and property.

On August 1, 1990, Tran incorporated Biomedcare Corporation, a California corporation with Tran- as its sole shareholder and president. On the surface, at least, Biomed-care’s business appears to be remarkably similar to that of the Debtor.

The Trustee has filed two adversary complaints against Tran. The first of those complaints, alleging that Tran, after the order for relief was entered, converted a $10,640 check belonging to the Debtor, was filed on June 4, 1991.2 The first count of this complaint claimed that Tran fraudulently converted a check the Debtor had received from Lindvall Medical Marketing and that, soon after the order for relief was entered, Tran cashed the check and kept the proceeds. The Trustee’s second count sought $100,000 in punitive damages from Tran for the fraudulent conversion of the check.3

On July 19, 1991, the Trustee filed a second adversary complaint against Tran and the Biomedcare Corporation.4 That complaint contained five counts: (1) Count I sought a declaratory judgment that the patents, the “Micros” trade name and certain related technology, intellectual property, and trade secrets were outgrowths of the patents and thus were property of the Debtor’s estate; (2) Count II sought to enjoin the Defendants from using the patents and related property; (3) Count III sought an accounting and damages from the Defendants for their illegal use of the Debtor’s patents; (4) Count IV was an action for conversion of the patents against the Defendants; and (5) Count V was an action for breach of fiduciary duty against Tran. Pursuant to court order, preliminary pretrial statements were filed on October 7, 1991 and on October 8, 1991, the court held an initial pretrial conference on all aspects of both complaints. On January 26, 1993, the court entered summary judgment for the Trustee on Count I of this complaint, finding that the patents, trademarks, manufacturing and production sequence and processes were assets of the Debtor’s estate.

On March 23,1993, the court set a Rule 16 pretrial conference on the remaining counts in both complaints for April 19, 1993. The court directed each of the remaining Defendants in the adversary proceedings to file pretrial statements by April 17, 1993. Before the pretrial conference was convened, Defendants’ counsel, Weissberg and Associates, filed a motion to withdraw.

On April 2, 1993, at the hearing on Weiss-berg’s motion to withdraw, Barrie Yacher, on behalf of the firm, Lobin & Soren, Ltd., attempted to substitute his appearance for the Defendants’ counsel. That motion led to the following exchange:

YACHER: Your Honor, what my office asked that I say for the record is that we are getting into the case for the purpose of negotiation, and the client understands that that is what we were being hired for. If we can’t work it out at the pretrial, then we are going to ask for leave to withdraw because we are not getting into the case for the purpose of trying it.
THE COURT: Mr. Yacher, as far as I’m concerned, you are in the case. I know I have never heard of somebody getting in and saying I’ll get in for negotiation and if I can’t settle it I am out. So it’s clear in your mind, those are the terms and conditions under which you come in. [522]*522If he [Tran] wants to hire a litigator, that’s his business. But until I let you out, you’re in.
YACHER: All right.
THE COURT: Okay?
YACHER: All right.

Having heard the court’s warning, the Lo-bin firm nevertheless substituted in for the Weissberg firm. Needless to say, neither the Weissberg nor Lobin firm filed the pretrial statements which were due on April 17, 1993 on behalf of the Defendants. At the April 19, 1993 pretrial conference, Marshall Lobin appeared on behalf of the Defendants. When the court inquired as to whether the Defendants would be filing pretrial statements in either adversary proceeding, Lobin stated that he was appearing only to discuss a possible settlement and was not there “to defend anything.” The failure of the Defendants to make an appropriate response to the court’s preliminary pretrial order and Lo-bin’s obvious lack of preparation for the conference, made the pretrial conference nugatory. As a result, the court was unable to schedule discovery and trial. It appeared to the court that the game of “musical lawyers” was a stalling tactic by the Defendants. Because of the Defendants’ actions to impede efficiency in the adversary process, the court determined that the most appropriate sanction to impose in this proceeding was default. The court hoped that such a sanction would convey the message to the Defendants’ various attorneys and the bankruptcy bar in the Northern District of Illinois that the court was serious about actively managing proceedings before it. Accordingly, on April 29 and April 30, 1993, the court entered default judgments against the Defendants.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Plogger v. IMC Mortgage Co. (In Re Plogger)
240 B.R. 243 (W.D. Virginia, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
163 B.R. 519, 28 Fed. R. Serv. 3d 845, 1994 Bankr. LEXIS 93, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maxwell-v-tran-in-re-controlled-release-technologies-inc-ilnb-1994.